Info & Diagnostics:
The PAP Foundation is a proud partner of the RLDC.
for PAP Patients
Savara Pharma will soon start enrolling PAP patients for their 'IMPALA 2' Phase 3 clinical trial involving MOLGRADEX (inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF) for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP).
Additional information will be posted here once it is released by Savara.
Phase 1 oral drug Pioglitazone trials are NOW ACTIVE for the East Coast (Cincinnati) PAP Clinical Center ONLY - CLICK HERE FOR DETAILS
If you suffer from PAP and are interested in learning about the clinical trials, or would like to receive updates and news about the fight against PAP, please complete the below to be on our contact list.
Sign up with the National PAP Registry:
You are eligible to sign up for the
National PAP Registry IF:
(1) You have been diagnosed with PAP by a doctor and (2) you are able to provide written informed consent.
The PURPOSE of the PAP Registry is to assemble and coordinate the PAP community to accelerate research and improve our understanding, diagnosis, and treatment of PAP.
If you are eligible and would like to participate, please
New PAP Blood Spot Diagnostic Test:
[Instructions & Procedures to obtain, complete & submit test - Coming Soon
RAW PAPKit Instructions can be accessed by CLICKING HERE]